Facility

Johnson & Johnson (NYSE:JNJ) announced today that it plans to increase its biopharmaceutical manufacturing presence in North Carolina. The company committed $2 billion toward a 160,000+-square-foot dedicated manufacturing facility at Fujifilm’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. Its commitment spans the next 10 years, expanding its U.S. manufacturing capacity and creating approximately…

Bionova Scientific, a subsidiary of Asahi Kasei, today announced the opening of a new plasmid DNA (pDNA) production facility in The Woodlands, Texas. The 10,000-square-foot, state-of-the-art development and production facility sits less than 30 miles north of Houston. It designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. pDNA…

Thermo Fisher Scientific recently announced plans to acquire Sanofi’s sterile manufacturing site in Ridgefield, New Jersey, and continue producing a portfolio of Sanofi therapies there while opening the facility to additional pharmaceutical and biotech customers. The plant performs sterile fill-finish and packaging, and has more than 200 employees, all of whom will join Thermo Fisher…

Varda Space Industries recently announced a $187 million fundraise, bringing the total amount of money raised to $329 million for the El Segundo, California–based startup. Natural Capital and Shrug Capital led the Series C round, with participation from Founders Fund, Peter Thiel, Khosla Ventures, Caffeinated Capital, Lux Capital, and Also Capital. Varda Space Industries’ goal…

Hikma Pharmaceuticals USA recently announced that it will invest $1 billion by 2030 to further expand U.S. manufacturing and R&D. London-based Hikma has already invested more than $4 billion over the past 15 years in expanding its U.S. presence, which was first established in 1991. The new “America Leans on Hikma” phase, announced June 28,…

Great Point Partners has acquired a majority stake in Eutecma, a Germany-based developer of reusable and modular temperature-controlled packaging for pharmaceutical cold chain logistics. The investment will support Eutecma’s global expansion strategy, particularly in the U.S. market, and bolster its efforts to reduce emissions and waste in drug shipping and storage. Eutecma supplies passive cooling…

Getting a manufacturing plant from investment to start-up as quickly as possible is a priority in almost every industry. Yet speed-to-market is even more important when it comes to a biotech or pharmaceutical facility. When going online means getting a lifesaving or health-improving solution into the hands of the people who need them, a heightened…

Fujifilm Diosynth Biotechnologies, a major contract development and manufacturing organization (CDMO), has entered into a 10-year manufacturing supply agreement with Regeneron Pharmaceuticals, valued at over $3 billion. The deal has the Fujifilm subsidiary providing U.S.-based manufacturing for Regeneron, with planned expansions at Fujifilm’s large-scale biopharmaceutical manufacturing facility in Holly Springs, North Carolina. The Holly Springs…

Johnson & Johnson today announced it broke ground on a $2 billion biologics manufacturing facility in Wilson, N.C., a small portion of the company’s $55 billion U.S. investment initiative over the next four years. The 500,000 ft² facility will expand the company’s capacity to develop and produce advanced therapies for oncology, immunology and neurological diseases.…

Sherwin-Williams High-Performance Flooring announced the launch of Accelera One, a grout and topcoat technology for pharmaceutical manufacturing environments. The technology offers benefits for pharmaceutical, life sciences, R&D and biopharma manufacturing spaces. A next-generation, ultra-high solids coating formulated to minimize downtime, it can also enhance durability and support green building goals. Accelera One delivers rapid cure…